首页> Med (New York, N.Y.)> Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease.

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yan,Hu

第一单位： Eisai Inc., Nutley, NJ, USA.

作者： Yan,Hu ^[1] ; Min,Cho ^[1] ; Pallavi,Sachdev ^[1] ; Jeffrey,Dage ^[2] ; Suzanne,Hendrix ^[3] ; Oskar,Hansson ^[4] ; Randall J,Bateman ^[5] ; Harald,Hampel ^[6]

作者单位： Eisai Inc., Nutley, NJ, USA. ^[1] Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. ^[2] Pentara Corporation, Millcreek, UT, USA. ^[3] Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Lund, Sweden; Memory Clinic, Skåne University Hospital, Malmö, Sweden. ^[4] Department of Neurology, Washington University of St. Louis, St. Louis, MO, USA; The Tracy Family SILQ Center, Washington University School of Medicine, Saint Louis, MO, USA. ^[5] Eisai Inc., Nutley, NJ, USA. Electronic address: harald_hampel@eisai.com. ^[6]

医学主题词阿尔茨海默病(Alzheimer Disease);人类(Humans);淀粉样β肽类(Amyloid beta-Peptides);疾病恶化(Disease Progression);抗体, 单克隆(Antibodies, Monoclonal)

DOI 10.1016/j.medj.2024.08.004

PMID 39255800

发布时间 2024-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Med (New York, N.Y.)

2024年5卷10期

1206-1226页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Med (New York, N.Y.)

2024年5卷10期

1206-1226页

检索历史清除

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease.

Med (New York, N.Y.)

相似文献

同项目论文

Med (New York, N.Y.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease.

Med (New York, N.Y.)

相似文献

同项目论文

Med (New York, N.Y.)

相关期刊

检索历史清除